• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Beta Bionics, Inc. iLet Bionic Pancreas; ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Beta Bionics, Inc. iLet Bionic Pancreas; ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP Back to Search Results
Model Number BB1001
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Hypoglycemia (1912); Loss of consciousness (2418)
Date of Event 08/11/2026
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2026 the reporter reported that on (b)(6) 2026 the user experienced hypoglycemia with blood glucose (bg) levels unknown.The user was transported to the hospital by paramedics where the user was treated with fluids and discharged (b)(6) 2026.No long-term health effects were reported.
 
Additional Manufacturer Narrative
The complaint investigation was performed by evaluation of the device engineering logs for the reported event date of (b)(6) 2026.No malfunction alerts or factory resets were identified.No motor errors were identified to indicate inaccurate insulin dosing relative to delivery requests.Review of the available data determined that the ilet was behaving as intended, alerts were triggered appropriately, and insulin dosing was adjusted in response to cgm glucose values.A dexcom g7 sensor was in use during the reported event.Brief sensor issues were observed; however, the available information does not establish that these sensor issues contributed to the reported hypoglycemic event.The user experienced hypoglycemia with loss of consciousness and was transported to the hospital by paramedics.The user was treated with fluids and discharged after blood glucose stabilized.The user and caregiver were unable to provide the blood glucose value associated with the event.The user subsequently resumed ilet therapy.The investigation did not identify an ilet device malfunction associated with the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
iLet Bionic Pancreas
Common Device Name
ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP
Manufacturer (Section D)
Beta Bionics, Inc.
11 hughes
irvine CA 92618
Manufacturer (Section G)
Beta Bionics, Inc.
11 hughes
irvine CA 92618
Manufacturer Contact
jared fukushima
11 hughes
irvine, CA 92618
+1(949)288-8350
MDR Report Key50515056
Report Number3019004087-2026-62595
Device Sequence Number21159545
Product Code QFG
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K231485
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Type of Report Initial
Report Date (Section B) 08/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model NumberBB1001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/12/2026
Initial Report FDA Received Date08/31/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/25/2026
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
Dexcom G7 CGM
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age63 YR
Patient SexMale
-
-